Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organic anion transporter 7 (OAT7; SLC22A9) is a membrane protein found predominantly on the sinusoidal (basolateral) membrane of hepatocytes in the human liver. It specifically transports sulfate conjugates of endogenous steroids (estrone 3-sulfate, dehydroepiandrosterone sulfate), xenobiotics, and the statin drug pravastatin into liver cells. The transporter operates an exchange mechanism with short-chain fatty acids such as butyrate, acting independently of sodium. It is not inhibited by probenecid (unlike other OATs) and is activated by SCFAs. OAT7 is implicated in hepatic drug uptake, hormone metabolism, and is associated with mismatch repair cancer syndrome. While its physiological and pathological roles are still being elucidated, OAT7 may be clinically important in pharmacokinetics and therapeutic modulation of drugs whose hepatic uptake relies on organic anion transport, particularly when other hepatic OATPs are compromised.
Transport/exchange of organic anion substrates (including sulfated steroids and pravastatin) into hepatocytes, often exchanging with short-chain fatty acids such as butyrate or valerate
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic anion transporter 7 (OAT7).